Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.079 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.073 | 0.7 |